Sponsor
Asger Lund, MD
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Asger Lund, MD appears in 5 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
5 shownThe Effect of Colchicine, on Insulin Sensitivity in Individuals With Type 1 Diabetes and Systemic Low-grade InflammationNCT07247734 · lead sponsor · 2025-12-01
RECRUITINGThe Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 DiabetesNCT07373236 · lead sponsor · 2026-01-23
COMPLETEDThe Separate and Combined Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Subjects With and Without Type 1 DiabetesNCT06881472 · lead sponsor · 2025-01-01
COMPLETEDRepurposing Colchicine for Reduction of Residual Inflammatory Risk in Type 1 DiabetesNCT05949281 · lead sponsor · 2023-08-29
ACTIVE_NOT_RECRUITINGThe Separate and Combined Effects of Long-term GIP and GLP-1 Receptor Activation in Patients with Type 2 DiabetesNCT05078255 · lead sponsor · 2022-01-27
COMPLETEDSponsor roles
lead sponsor5
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.